[go: up one dir, main page]

GB201121236D0 - Proteins and peptides - Google Patents

Proteins and peptides

Info

Publication number
GB201121236D0
GB201121236D0 GBGB1121236.2A GB201121236A GB201121236D0 GB 201121236 D0 GB201121236 D0 GB 201121236D0 GB 201121236 A GB201121236 A GB 201121236A GB 201121236 D0 GB201121236 D0 GB 201121236D0
Authority
GB
United Kingdom
Prior art keywords
peptides
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1121236.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB1121236.2A priority Critical patent/GB201121236D0/en
Publication of GB201121236D0 publication Critical patent/GB201121236D0/en
Priority to PH1/2014/500380A priority patent/PH12014500380A1/en
Priority to UAA201401344A priority patent/UA118833C2/en
Priority to BR112014003679-9A priority patent/BR112014003679B1/en
Priority to EP17191815.4A priority patent/EP3339322A3/en
Priority to CN201280051150.4A priority patent/CN103917557B/en
Priority to CA2845029A priority patent/CA2845029A1/en
Priority to MX2014001883A priority patent/MX2014001883A/en
Priority to MYPI2014700336A priority patent/MY167125A/en
Priority to AU2012296961A priority patent/AU2012296961B2/en
Priority to UY0001034254A priority patent/UY34254A/en
Priority to KR1020197027997A priority patent/KR102143506B1/en
Priority to ARP120102955A priority patent/AR087521A1/en
Priority to US14/239,196 priority patent/US10808040B2/en
Priority to ES12746095T priority patent/ES2813432T3/en
Priority to EP12746095.4A priority patent/EP2744822B1/en
Priority to CN201810128962.3A priority patent/CN108178800B/en
Priority to TW101129262A priority patent/TW201321405A/en
Priority to NZ621203A priority patent/NZ621203B2/en
Priority to JP2014525418A priority patent/JP6297976B2/en
Priority to SG10201605891TA priority patent/SG10201605891TA/en
Priority to PCT/EP2012/065782 priority patent/WO2013024059A2/en
Priority to EA201490262A priority patent/EA027160B1/en
Priority to PE2014000214A priority patent/PE20141522A1/en
Priority to SG2014010482A priority patent/SG2014010482A/en
Priority to KR1020147006909A priority patent/KR102162413B1/en
Priority to EP15180982.9A priority patent/EP2987806A3/en
Priority to IL230918A priority patent/IL230918A0/en
Priority to CO14029997A priority patent/CO7020851A2/en
Priority to DO2014000029A priority patent/DOP2014000029A/en
Priority to MA36807A priority patent/MA35428B1/en
Priority to HK16102229.1A priority patent/HK1214281A1/en
Priority to AU2016277685A priority patent/AU2016277685B2/en
Priority to JP2018029267A priority patent/JP2018117623A/en
Priority to AU2019201505A priority patent/AU2019201505A1/en
Priority to JP2019222041A priority patent/JP6979446B2/en
Priority to US17/014,441 priority patent/US20210017293A1/en
Priority to US18/893,457 priority patent/US20250136721A1/en
Ceased legal-status Critical Current

Links

GBGB1121236.2A 2011-08-17 2011-12-12 Proteins and peptides Ceased GB201121236D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GBGB1121236.2A GB201121236D0 (en) 2011-12-12 2011-12-12 Proteins and peptides
EP15180982.9A EP2987806A3 (en) 2011-08-17 2012-08-13 Modified single variable domain antibodies with reduced binding to anti-drug-antibodies
NZ621203A NZ621203B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
JP2014525418A JP6297976B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
BR112014003679-9A BR112014003679B1 (en) 2011-08-17 2012-08-13 SINGLE IMMUNOGLOBULIN VARIABLE DOMAIN, PHARMACEUTICAL COMPOSITION, FORMULATION, ISOLATED OR RECOMBINANT NUCLEIC ACID, VECTOR, TRANSGENIC MICROORGANISM, AND, USE OF A PHARMACEUTICAL COMPOSITION
EP17191815.4A EP3339322A3 (en) 2011-08-17 2012-08-13 Immunoglobulin single variable domain antibodies with a c-terminal extension for reduced immunogenicity
CN201280051150.4A CN103917557B (en) 2011-08-17 2012-08-13 Modified single variable domain antibodies with reduced binding to anti-drug antibodies
CA2845029A CA2845029A1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
MX2014001883A MX2014001883A (en) 2011-08-17 2012-08-13 Modified proteins and peptides.
MYPI2014700336A MY167125A (en) 2011-08-17 2012-08-13 Modified proteins and peptides
AU2012296961A AU2012296961B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
PCT/EP2012/065782 WO2013024059A2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
KR1020197027997A KR102143506B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
ARP120102955A AR087521A1 (en) 2011-08-17 2012-08-13 PROTEINS AND MODIFIED PEPTIDES
US14/239,196 US10808040B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
ES12746095T ES2813432T3 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
EP12746095.4A EP2744822B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
CN201810128962.3A CN108178800B (en) 2011-08-17 2012-08-13 Modified Single Variable Domain Antibodies with Reduced Binding to Antidrug Antibodies
TW101129262A TW201321405A (en) 2011-08-17 2012-08-13 Modified protein and peptide
PH1/2014/500380A PH12014500380A1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
SG10201605891TA SG10201605891TA (en) 2011-08-17 2012-08-13 Modified proteins and peptides
UAA201401344A UA118833C2 (en) 2011-08-17 2012-08-13 THE ONLY VARIABLE DOMAIN OF IMMUNOGLOBULIN, WHICH Binds to TNFR1
UY0001034254A UY34254A (en) 2011-08-17 2012-08-13 PROTEINS AND MODIFIED PEPTIDES.
EA201490262A EA027160B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
PE2014000214A PE20141522A1 (en) 2011-08-17 2012-08-13 PROTEINS AND MODIFIED PEPTIDES
SG2014010482A SG2014010482A (en) 2011-08-17 2012-08-13 Modified proteins and peptides
KR1020147006909A KR102162413B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
IL230918A IL230918A0 (en) 2011-08-17 2014-02-11 Modified proteins and peptides
CO14029997A CO7020851A2 (en) 2011-08-17 2014-02-12 Proteins and modified peptides
DO2014000029A DOP2014000029A (en) 2011-08-17 2014-02-17 PROTEINS AND MODIFIED PEPTIDES.
MA36807A MA35428B1 (en) 2011-08-17 2014-03-06 Proteins and peptides podified
HK16102229.1A HK1214281A1 (en) 2011-08-17 2014-06-26 Modified single variable domain antibodies with reduced binding to anti-drug-antibodies
AU2016277685A AU2016277685B2 (en) 2011-08-17 2016-12-22 Modified proteins and peptides
JP2018029267A JP2018117623A (en) 2011-08-17 2018-02-22 Modified proteins and peptides
AU2019201505A AU2019201505A1 (en) 2011-08-17 2019-03-05 Modified proteins and peptides
JP2019222041A JP6979446B2 (en) 2011-08-17 2019-12-09 Modified proteins and peptides
US17/014,441 US20210017293A1 (en) 2011-08-17 2020-09-08 Modified proteins and peptides
US18/893,457 US20250136721A1 (en) 2011-08-17 2024-09-23 Modified proteins and peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1121236.2A GB201121236D0 (en) 2011-12-12 2011-12-12 Proteins and peptides

Publications (1)

Publication Number Publication Date
GB201121236D0 true GB201121236D0 (en) 2012-01-18

Family

ID=45541516

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1121236.2A Ceased GB201121236D0 (en) 2011-08-17 2011-12-12 Proteins and peptides

Country Status (1)

Country Link
GB (1) GB201121236D0 (en)

Similar Documents

Publication Publication Date Title
IL230918A0 (en) Modified proteins and peptides
IL260045B (en) Polypeptide constructs and uses thereof
ZA201404962B (en) Modified mini-hepcidin peptides and methods of using thereof
IL279676A (en) Recombinant proteins and their therapeutic uses
IL222961A0 (en) Novel dna-dinding proteins and uses thereof
ZA201400562B (en) Axmi205 variant proteins and methods for their use
SG11201500111VA (en) Peptides and uses thereof
SG2014010334A (en) Fn14 binding proteins and uses thereof
SG11201501646PA (en) Peptides and their uses
GB201111183D0 (en) Peptide
ZA201309679B (en) Amylin peptides and derivatives and uses thereof
PL2668205T3 (en) Human lactoferrin derived peptides and their use
EP2825548A4 (en) Modified kisspeptin peptides and uses thereof
SG11201402139UA (en) High mast2-affinity polypeptides and uses thereof
GB201115910D0 (en) Peptides
PL2627668T3 (en) Peptides and uses
IL229956B (en) Mphosphi peptides and vaccines including the same
EP2762149A4 (en) Erythropoietin-derived peptide and use therefor
SG11201404180RA (en) Cho-gmt recombinant protein expression
EP2771689A4 (en) Usp2a peptides and antibodies
GB201121236D0 (en) Proteins and peptides
GB201121226D0 (en) Modified proteins and peptides
GB201121233D0 (en) Modified proteins and peptides
HK1192893A (en) Modified proteins and peptides
GB201214769D0 (en) Methodsa and peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)